Considerations for the review of patient-focused development of antitumor drugsTANG Ling, ZHOU Ming, XIA Lin, TONG Xin, HAO Ruimin, ZHAO Xiao, SONG Yuanyuan, CHEN Dongmei, DU Yu, YANG Zhimin577-582
Expression and prognostic value of glucose transporter 1 in patients with hepatocellular carcinomaZHENG Xia, ZHANG Yuanjing, GOU Yudong, WEI Qi, WEI Sihui, YANG Zhihui, QIN Shukui583-589
Expression and clinical significance of IL-6, STT3A and PD-L1 in gastric cancer tissuesTANG Jiaqi, HU Nan, WANG Huiyu, ZHANG Jingzhou, HONG Yidong, BIAN Baoxiang, SONG Ziyan, WU Fenglei590-595
The significance and expression of PFKP and CD133 in gastric cancerHU Pingping, CHEN Miao, SHAO Rui, XUE Di, MIAO Zhicheng596-601
Risk factors of postoperative lower limb lymphedema following lymphadenectomy in gynecologic malignanciesWANG Jianli, LI Zhuang, JIANG Lingling, YAO Desheng602-606
Clinical study on optimization of sacral limit in IMRT for cervical cancerCHU Anhong, GUO Qi, CAI Shang, QIAN Jianjun, TIAN Ye607-614
Clinical observation of induction chrono-chemotherapy or adjuvant chrono-chemotherapy combined with cisplatin concurrent radiochemotherapy for locally advanced nasopharyngeal carcinomaSHU Hongbo, JIN Feng, WU Weili, LI Yuanyuan, LUO Xiuling, LONG Jinhua, GONG Xiuyun, CHEN Xiaoxiao, ZHAO Chaofen, HE Qianyong, LIU Lina, LI Zhuoling, BI Ting615-621
Construction and validation of a prognostic nomogram for children with rhabdomyosarcomaZHANG Lin, XIONG Hao, LI Jianxin, LI Hui, TAO Fang, WANG Zhuo, NIE Yingming, CHEN Zhi, TANG Wei, TENG Juxian622-628
Clinical study of chloroquine in combination with cisplatin-based regimen as the first-line treatment for HER-2 negative advanced gastric cancerHE Bo, XIONG Shuping, SHEN Xiaohua, ZHONG Huaqiang, WAN Yiye, ZHANG Huiqing629-632
Analysis of the development trajectory of home functional exercise compliance in breast cancer patients after modified radical mastectomyCHU Xiaomin, XU Qin, LOU Ying, WANG Zijun, ZHANG Yan633-637
